Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/phpp.12445 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Case of Ramipril-Induced Angioedema and Solar Purpura.
Adv Skin Wound Care
January 2025
In the Department of Dermatology, Faculty of Medicine, Sakarya University, Turkey, Rabia Oztas Kara, MD, is Assistant Professor and Bahar Sevimli Dikicier, MD, is Associate Professor. In the Department of Pathology, Bilge Elcin, MD, is Specialist.
This case report describes a patient who developed solar purpura after treatment for angioedema associated with ramipril, an angiotensin-converting enzyme inhibitor. The patient presented to the ED with angioedema. She had been using ramipril for 2 years.
View Article and Find Full Text PDFNew insights into chronic inducible urticaria.
Curr Allergy Asthma Rep
August 2024
Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 10178, Berlin, Germany.
Article Synopsis
- Chronic inducible urticaria (CIndU) is a difficult-to-manage condition marked by recurring hives and swelling, triggered by specific factors, and recent research has focused on understanding its causes and improving treatment options.
- New methods for evaluating patient experiences have been developed, highlighting the significant impact CIndU has on quality of life and enabling better diagnosis through provocation tests for different subtypes.
- Currently, second-generation non-sedating antihistamines are the primary recommended treatment, but they often fall short; however, off-label use of omalizumab shows promise, along with other emerging therapies being researched for future options.
Chronic Inducible Urticaria.
Immunol Allergy Clin North Am
August 2024
Department of Dermatology and Venerology, Kepler University Hospital, Urticaria Center of Excellence and Reference (UCARE), Linz, Austria; Center for medical research, Johannes Kepler University, Linz, Austria; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany. Electronic address:
Article Synopsis
- * Diagnosis relies on patient history, trigger tests, and self-reported symptoms.
- * Current treatments mirror those for chronic spontaneous urticaria but are largely off-label; new targeted therapies are in clinical trials due to the significant impact on patients.
Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses.
J Allergy Clin Immunol Pract
August 2023
Department of Dermatology, Mayo Clinic, Rochester, Minn. Electronic address:
Article Synopsis
- Chronic urticaria is an itchy skin condition that lasts for at least 6 weeks, with both spontaneous cases (no clear triggers) and inducible cases (specific triggers like heat or cold).
- Angioedema is another condition that involves swelling beneath the skin, often occurring alongside chronic urticaria, but it lasts longer and can have different causes.
- Accurate diagnosis is crucial since chronic urticaria and angioedema can be confused with other conditions, impacting treatment and outcomes for patients.
Physical urticaria: Clinical features, pathogenesis, diagnostic work-up, and management.
J Am Acad Dermatol
August 2023
St. John's Institute of Dermatology, Guy's Hospital, London, England.
Article Synopsis
- * Symptoms can vary and may include localized skin reactions, mucosal involvement, and systemic issues like nausea or headaches, potentially leading to severe reactions like anaphylaxis.
- * Accurate diagnosis of physical urticaria requires detailed clinical assessment and testing, which are essential for effective treatment and management strategies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!